针对接受局限性前列腺癌治疗的男性，寻找更好的预后因素的工作仍在继续。 - Suppr | 超能文献

The search for better prognostic factors for men treated for localized prostate cancer continues.

作者信息

Karakiewicz Pierre I, Suardi Nazareno, Shariat Shahrokh F

出版信息

Eur Urol. 2008 Apr;53(4):689-90. doi: 10.1016/j.eururo.2007.12.009. Epub 2007 Dec 17.

DOI:10.1016/j.eururo.2007.12.009

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The search for better prognostic factors for men treated for localized prostate cancer continues.针对接受局限性前列腺癌治疗的男性，寻找更好的预后因素的工作仍在继续。

Eur Urol. 2008 Apr;53(4):689-90. doi: 10.1016/j.eururo.2007.12.009. Epub 2007 Dec 17.

2

Can we accurately identify men with low risk prostate cancer?我们能否准确识别出患有低风险前列腺癌的男性？

J Urol. 2008 Oct;180(4):1217-8. doi: 10.1016/j.juro.2008.07.086. Epub 2008 Aug 15.

3

Localized prostate cancer: can we better define who is at risk of unfavourable outcome?局限性前列腺癌：我们能否更好地界定哪些人有不良预后风险？

BJU Int. 2008 Mar;101 Suppl 2:5-10. doi: 10.1111/j.1464-410X.2007.07488.x.

4

Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.低风险前列腺癌患者的治疗前前列腺特异性抗原变化率与前列腺癌死亡风险

J Clin Oncol. 2009 Aug 1;27(22):3575-6. doi: 10.1200/JCO.2009.22.6068. Epub 2009 Jun 8.

5

Evaluating localized prostate cancer and identifying candidates for focal therapy.评估局限性前列腺癌并确定聚焦治疗的候选者。

Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.

6

Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.临床局限性前列腺癌的预处理分期。美国放射学会。ACR适宜性标准。

Radiology. 2000 Jun;215 Suppl:703-8.

7

It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer.是时候摒弃前列腺特异性抗原的正常上限了：评估前列腺癌风险。

J Urol. 2008 Oct;180(4):1219-22. doi: 10.1016/j.juro.2008.07.089. Epub 2008 Aug 15.

8

What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.新诊断前列腺癌患者中适合进行监测的比例是多少？对CaPSURE数据库的分析。

J Urol. 2008 Oct;180(4):1330-4; discussion 1334-5. doi: 10.1016/j.juro.2008.06.019. Epub 2008 Aug 15.

9

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.在重复活检时诊断出的前列腺癌体积较小，且高级别癌的可能性较低。

J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.

10

Percentage of positive biopsy cores at the onset of hormone therapy for prostate cancer: prognostic significance.前列腺癌激素治疗开始时活检阳性核心的百分比：预后意义

Urol Int. 2009;83(2):160-5. doi: 10.1159/000230017. Epub 2009 Sep 10.